Application of Histopathological Disease Activity Indices in Ulcerative Colitis
PENG Ying1，XU Lihong1，2*
1.Shihezi University School of Medicine，Shihezi 832000，China
2.Department of Gastroenterology，Affiliated Fifth People's Hospital of Chengdu University of TCM，Chengdu 611130，China
*Corresponding author：XU Lihong，Master supervisor；E-mail：xueli_2006@126.com
［1］PAI R K，GEBOES K.Disease activity and mucosal healing in inflammatory bowel disease：a new role for histopathology?［J］．Virchows Arch，2018，472（1）：99-110．DOI：10.1007/s00428-017-2156-5.
［2］LEMMENS B，ARIJS I，VAN ASSCHE G，et al．Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis［J］．Inflamm Bowel Dis，2013，19（6）：1194-1201．DOI：10.1097/mib.0b013e318280e75f.
［3］TRUELOVE S C，RICHARDS W C.Biopsy studies in ulcerative colitis［J］．Br Med J，1956，1（4979）：1315-1318．DOI：10.1136/bmj.1.4979.1315.
［4］RILEY S A，MANI V，GOODMAN M J，et al．Microscopic activity in ulcerative colitis：what does it mean?［J］．Gut，1991，32（2）：174-178．DOI：10.1136/gut.32.2.174.
［5］GEBOES K，RIDDELL R，OST A，et al．A reproducible grading scale for histological assessment of inflammation in ulcerative colitis［J］．Gut，2000，47（3）：404-409．DOI：10.1136/gut.47.3.404.
［6］MAGRO F，LOPES J，BORRALHO P，et al．Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels［J］．Gut，2019，68（4）：594-603．DOI：10.1136/gutjnl-2017-315545.
［7］BRESSENOT A，SALLERON J，BASTIEN C，et al．Comparing histological activity indexes in UC［J］．Gut，2015，64（9）：1412-1418．DOI：10.1136/gutjnl-2014-307477.
［8］ZENLEA T，YEE E U，ROSENBERG L，et al．Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission：a prospective study［J］．Am J Gastroenterol，2016，111（5）：685-690．DOI：10.1038/ajg.2016.50.
［9］TANAKA M，KUSUMI T，OSHITANI N，et al．Validity of simple mucosal biopsy criteria combined with endoscopy predicting patients with ulcerative colitis ultimately requiring surgery：a multicenter study［J］．Scand J Gastroenterol，2003，38（6）：594-598．DOI：10.1080/00365520310000564.
［10］VILLANACCI V，ANTONELLI E，REBOLDI G，et al．Endoscopic biopsy samples of na?ve “colitides” patients：Role of basal plasmacytosis［J］．J Crohns Colitis，2014，8（11）：1438-1443．DOI：10.1016/j.crohns.2014.05.003.
［11］CANAVESE G，VILLANACCI V，ANTONELLI E，et al．Eosinophilia - associated basal plasmacytosis：an early and sensitive histologic feature of inflammatory bowel disease［J］．APMIS，2017，125（3）：179-183．DOI：10.1111/apm.12639.
［12］YANTISS R K，ODZE R D.Diagnostic difficulties in inflammatory bowel disease pathology［J］．Histopathology，2006，48（2）：116-132．DOI：10.1111/j.1365-2559.2005.02248.x.
［13］TANAKA M，SAITO H，FUKUDA S，et al．Simple mucosal biopsy criteria differentiating among Crohn disease，ulcerative colitis，and other forms of colitis：measurement of validity［J］．Scand J Gastroenterol，2000，35（3）：281-286．DOI：10.1080/003655200750024155.
［14］LEONCINI G，VILLANACCI V，MARIN M G，et al．Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy［J］．Tech Coloproctology，2018，22（12）：941-946．DOI：10.1007/s10151-018-1896-9.
［15］ALHMOUD T，GREMIDA A，COLOM STEELE D，et al．Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation［J］．BMJ Open Gastroenterol，2020，7（1）：e000373．DOI：10.1136/bmjgast-2020-000373.
［16］FEAGAN B G，GREENBERG G R，WILD G，et al．Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin［J］．N Engl J Med，2005，352（24）：2499-2507．DOI：10.1056/nejmoa042982.
［17］MOSLI M H，FEAGAN B G，SANDBORN W J，et al．Histologic evaluation of ulcerative colitis：a systematic review of disease activity indices［J］．Inflamm Bowel Dis，2014，20（3）：564-575．DOI：10.1097/01.MIB.0000437986.00190.71.
［18］MARCHAL-BRESSENOT A，SALLERON J，BOULAGNON-ROMBI C，et al．Development and validation of the Nancy histological index for UC［J］．Gut，2017，66（1）：43-49．DOI：10.1136/gutjnl-2015-310187.
［19］MAGRO F，LOPES J，BORRALHO P，et al．Comparison of the nancy index with continuous Geboes score：histological remission and response in ulcerative colitis［J］．J Crohns Colitis，2020，14（7）：1021-1025．DOI：10.1093/ecco-jcc/jjaa010.
［20］MOSLI M H，FEAGAN B G，ZOU G，et al．Development and validation of a histological index for UC［J］．Gut，2017，66（1）：50-58．DOI：10.1136/gutjnl-2015-310393.
［21］MAGRO F，LOPES J，BORRALHO P，et al．Comparing the continuous Geboes score with the Robarts Histopathology Index：definitions of histological remission and response and their relation to faecal calprotectin levels［J］．J Crohns Colitis，2020，14（2）：169-175．DOI：10.1093/ecco-jcc/jjz123.
［22］JAUREGUI-AMEZAGA A，GEERITS A，DAS Y，et al．A simplified geboes score for ulcerative colitis［J］．J Crohns Colitis，2017，11（3）：305-313．DOI：10.1093/ecco-jcc/jjw154.
［23］MITSUISHI T.Correlation between histological findings and endoscopic findings in patients with ulcerative colitis：Basal plasmacytosis is an important finding suggesting active inflammation［J］．JGH Open，2019，3（2）：100-104．DOI：10.1002/jgh3.12111.
［24］VILLANACCI V，ANTONELLI E，LANZAROTTO F，et al．Usefulness of different pathological scores to assess healing of the mucosa in inflammatory bowel diseases：a real life study［J］．Sci Rep，2017，7（1）：6839．DOI：10.1038/s41598-017-07338-x.
［25］MAVROUDIS G，MAGNUSSON M K，ISAKSSON S，et al．Mucosal and systemic immune profiles differ during early and late phases of the disease in patients with active ulcerative colitis［J］．J Crohns Colitis，2019，13（11）：1450-1458．DOI：10.1093/ecco-jcc/jjz072.
